Study-Level Dataset for Pharmacist-Involved Services for Cardiometabolic Conditions in China: A Systematic Review and Meta-Analysis

This dataset accompanies the systematic review and meta-analysis “Pharmacist-involved services for cardiometabolic conditions in China.” It contains the study-level data used to synthesise evidence from 266 randomised controlled trials involving 37,066 participants, comprising 1,107 effect estimates across 21 outcomes. The dataset includes study characteristics, intervention and comparator information, disease classifications, follow-up, outcome data, effect estimates, and variables used in sensitivity, moderator, risk-of-bias, and related robustness analyses, where applicable.

Outcomes cover medication use, patient-important outcomes, disease-control measures, healthcare-resource use, and reported expenditure components. Supporting data for analyses of adherence measurement, unplanned readmission, outcome-specific risk of bias, trial trustworthiness, and the sampled non-core-journal validation are also included. The files are provided to facilitate transparency, reproducibility, independent verification, and reuse of the aggregate study-level evidence.